Pilot Decentralized Trial

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

NCT02085135 ·Status: COMPLETED ·Phase: PHASE3

Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder

NCT01733654 ·Status: WITHDRAWN ·Phase: PHASE2

ANC-501 in the Treatment of Adults With Major Depressive Disorder

NCT05439603 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

NCT00785434 ·Status: COMPLETED ·Phase: PHASE4

An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

NCT04433858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111552 ·Status: TERMINATED ·Phase: PHASE3

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

NCT00759395 ·Status: COMPLETED ·Phase: PHASE2

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01123707 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111539 ·Status: TERMINATED ·Phase: PHASE3

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

NCT04937829 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT05061719 ·Status: COMPLETED ·Phase: PHASE3

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

NCT04975724 ·Status: RECRUITING ·Phase: PHASE4

Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study

NCT01152996 ·Status: COMPLETED ·Phase: PHASE3

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

NCT00239954 ·Status: UNKNOWN ·Phase: PHASE3

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

NCT02271412 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)

NCT00035282 ·Status: COMPLETED ·Phase: PHASE3

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

NCT01156415 ·Status: TERMINATED ·Phase: PHASE3

Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder

NCT02660528 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

NCT00411099 ·Status: COMPLETED ·Phase: PHASE3

Study of Naltrexone-Induced Blockade of Antidepressant Effects

NCT04322526 ·Status: COMPLETED ·Phase: PHASE4

AZD6765 for Treatment Resistant Depression

NCT00491686 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Pharmacokinetics Study of LY03005

NCT02055300 ·Status: COMPLETED ·Phase: PHASE1

AZD7268 Safety and Tolerability Study

NCT01020799 ·Status: COMPLETED ·Phase: PHASE2

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT05850689 ·Status: RECRUITING ·Phase: PHASE3

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

NCT01110889 ·Status: COMPLETED ·Phase: PHASE3